expressed in dorsal root ganglion neuron, a pain sensing neuron, which is a target for analgesics. In this study, a reliable 3D structure for transmembrane (TM) region of mouse TRESK (mTRESK) was constructed, and then the reasonable blocker binding mode of the protein was investigated. The 3D structure of the mTRESK built by homology modeling method was validated with recommend value of stereochemical quality. Based on the validated structure, K + channel blocker-bound conformation was obtained by molecular docking and 5 ns MD simulation with DPPC lipid bilayer. Our docking study provides the plausible binding mode of known blockers with key interacting residues, especially, F156 and F364. Finally, these modeling results were verified by experimental study with mutation from phenylalanine to alanine (F156A, F364A and F156A/F364A) at the TM2 and TM4. This is the first modeling study for TRESK that can provide structural information of the protein including ligand binding information. These results can be useful in structure based drug design for finding new blockers of the TRESK as potential therapeutic target of pain treatment.
Introduction
Potassium channels (K + channels) play important roles in the regulation of cell growth, cell excitability, cell volume, and proliferation, as well as cell death. All K + channels share a common functional feature with respect to selectivity for K + ions. It is associated with a conserved TVGYG motif which is important for selectivity filter of the poreforming region (P-domain or P-loop) of the channel proteins [1] [2] [3] [4] . The K + channels are characterized by the number of transmembrane (TM) domains (two, four, or six) and P-loops (one or two) [5] .
The two-pore-domain K + (K 2P ) channels contribute to the background (or leak) K + currents, which are responsible for the resting membrane potential and excitability of several excitable and nonexcitable cell types in mammalian [6, 7] . In heterologous systems, K 2P channels could act as putative targets for various factors, including drugs. The mammalian K 2P channel family consists of 15 members, and it can be divided into six subfamilies based on amino acid homology, and their structural and functional properties: TWIK (TWIK-1, TWIK-2, and KCNK7), TREK (TREK-1, TREK-2, and TRAAK), TASK (TASK-1, TASK-3, and TASK-5), TALK (TALK-1, TALK-2, and TASK-2), THIK (THIK-1 and THIK-2), and TRESK [1, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . The channels play a key role in cellular mechanisms of neuroprotection, anesthesia, pain, and depression. In addition, they are modulated by cellular lipids, pharmacological agents, polyunsaturated fatty acids, and volatile general anesthetics [16] . Each subunit of K 2P channels consists of four TM domains (TM1-TM4) and two P-loops, and two subunits assemble to form a functional dimeric K + channel. Moreover, the channels possess an evolutionarily conserved extended extracellular loop between TM1 and P1 (TM1-P1 loop), and the P-loop of K 2P channels contains a consensus sequence motif of TxG(Y/F)G [7, 11, 16, 18, 22, 23] . TWIK (tandem-pore domain weak inward rectifying K + )-related spinal cord K + channel (TRESK), a member of the tandem-pore domain K + channel family, is the most recently cloned K 2P channel. Its mRNA was expressed in a specific region of the human spinal cord and mouse cerebellum, cerebrum, spleen, thymus as well as testis, cerebral cortex, and especially dorsal root ganglion (DRG) [8, 21, 24, 25] . Hydrophobicity analysis of the amino acid sequence for mouse TRESK (mTRESK) channel revealed that the channel has two P-loops, four TM domains, and one N-glycosylation sites in the TM1-P1 linker region which are similar to the other K 2P channels. In addition, the TRESK consists of extended intracellular loop between TM2 and TM3 and a short C-terminal and N-terminal regions which located on the intracellular side [21] . The TRESK is modulated by various intracellular and extracellular factors such as arachidonic acid, Zn 2+ , volatile anesthetics, and GPCR agonists [8, [26] [27] [28] [29] . This channel is uniquely regulated by the calcium signal compared to the other K 2P channels [24] . Because mTRESK include an NFAT (nuclear factor of activated T-cells)-like consensus motif for calcineurin binding such as PQIVID in mouse (PQIIIS in human) at its intracellular loop between TM2 and TM3 (TM2-TM3 loop), it is activated in response to the calcium signal through binding calcineurin, a calcium/calmodulin-dependent protein phosphatase [30] . Therefore, Cyclosporine A and FK506, immunosuppressive compounds, which are calcineurin inhibitors widely used as immunosuppressors in the clinic, prevent TRESK activation. The activation of TRESK could induce activation of the transcription of new genes as well as regulation of several aspects of T-cell function, therefore the channel is considered as a potential target to treat T-cell mediated immune dysfunction [24, 30, 31] .
Several studies reported K 2P homology modeled structure such as TASK-1, TASK-2 and TALK-2, and TREK-1 and TREK-2 [17, [32] [33] [34] [35] . The TRESK is highly expressed in dorsal root ganglion neuron, a pain sensing neuron, which is a target for analgesics. However, little is known about the 3D structure and drug binding site of TRESK compared with other K 2P channels. Therefore, the main objectives of this study are to construct 3D structure of mTRESK and to predict K + channel blocker binding site. In this study, reasonable modeled structures of mTRESK were generated using homology modeling method. A suitable binding mode of known K + channel blockers into mTRESK structure was predicted, and key interacting residues in blocker binding site were suggested in our molecular docking study. In order to verify our modeling study, three TRESK mutants (F156A, F364A, and F156A/F364A) were constructed. The TRESK currents were measured using whole-cell recording, a technique that measures the movement of ions across the cell membrane. Pharmacological agents were tested at the cellular levels. Our modeling results provide the structural insight into blocker binding site of TRESK, this will be help to design structure-based drugs for TRESK as a potential therapeutic target in pain treatment.
Materials and methods

Prediction of transmembrane helices
The mTRESK sequence including 394 amino acids was obtained from UniProt (http://www.uniprot.org) (UniProt ID: Q6VV64). TMHMM v2.0 which is available at CBS (Center for Biological Sequence analysis, http://www.cbs.dtu.dk/services/TMHMM) was used to predict transmembrane helices (TMHs) of mTRESK. The program is a method for prediction of TMHs based on a hidden Markov model [36] .
Generation of 3D structure
Sequence database search was carried out with blastp and PSI-BLAST tools in NCBI (www.ncbi.nlm.nih.gov) to identify the homologue of known structure from the PDB for template proteins of mTRESK. The coordinates of MthK channel (PDB ID: 3LDC, 1.45 Å resolution) were selected as a template to build the initial mTRESK structure. Sequence alignment between mTRESK and template was performed by ClustalW2 program (http://www.ebi.ac.uk/Tools/clustalw2/index.html) [37] . Based on the alignment, the 3D structure of mTRESK was constructed using Build homology model protocol within Discovery studio 2.5 (DS2.5) (Accelrys Inc., San Diego, USA). Two models were separately generated depending on the extended TM1-P1 loop: Model 1 without loop, Model 2 with edited helices in loop region. The build and edit protein tool was applied to predict secondary structure as right-hand alpha helix for the extended loop, the range of these helices was calculated by Predict command in Secondary Structure from Sequence menu in DS2.5. The orientation coordinates for monomer and homodimer of mTRESK structure were obtained by superimposition of the constructed homology models with KcsA K + channel structure (PDB ID: 1J95).
Solvated energy minimization and validation of 3D structure
Solvated energy minimization (EM) was carried out using the GROMACS program (version 4.5.1) [38, 39] with GROMOS96 53a6 force field to refine the homology modeled structure. The initial structures were inserted to an orthorhombic water box (1 nm thickness), and the system was neutralized with the addition of 14 K + counterions by replacing water molecules. Long range electrostatics were handled using the PME (particle mesh Ewald) method [40] . In a system, protein alone consists of 4892 atoms and the entire system is made up of 101228 atoms in 32112 water molecules. To remove the possible bad contacts from the initial structures, the steepest descent EM algorithm was applied until energy convergence at 2000 kJ mol −1 nm −1 . The energy minimized structures were validated by three programs such as PROCHECK, ProSA-web (https://prosa.services.came.sbg.ac.at/ prosa.php), and ERRAT version 2.0 (http://nihserver.mbi.ucla.edu/ ERRATv2/). The PROCHECK program was implemented to check the stereochemical quality of protein structures with Ramachandran plot [41] . The ProSA and ERRAT were also executed to evaluate the constructed structures. The ProSA is an established tool which is frequently employed in the refinement and validation of experimental protein structures, structure prediction, and modeling [42] . ERRAT is a protein structure verification algorithm that is especially well-suited for evaluating the progress of crystallographic model building and refinement [43] .
Pore radius analysis
The HOLE program (http://hole.biop.ox.ac.uk/hole) [44, 45] was utilized for analysis and visualization of the pore dimensions in homology modeled mTRESK structure. The VMD program [46] was used to visualize and to compare the pore surfaces between the template and mTRESK.
Molecular dynamics simulation in explicit membrane environment
The minimized mTRESK model was oriented perpendicularly to the membrane plane by Add Membrane and Orient Molecule Tool in DS2.5 and then it was subjected to the molecular dynamics (MD) simulation with explicit membrane [47] [48] [49] [50] . The coordinate and topology of the DPPC containing 128 lipids for GROMACS were obtained from the Web site of D. Peter Tieleman (http://moose.bio.ucalgary.ca). The proper membrane system of 512 DPPCs was constructed based on the extension of 128 DPPCs. The GROMOS 53a6 force field [51] was applied with added lipid parameters developed by Berger et al. [52] . Initial structure was embedded in DPPC bilayer and solvated with SPC (simple point charge) water model [53] . The coordinate and topology of GROMACS for propafenone which shown the highest fitness score in pre-docking study were derived from PRODRG server [54] The systems were neutralized by the addition of 14 K + counterions. The protein alone consists of 4448 atoms and the entire system is made up of 129,303 atoms containing 33,135 water molecules and 508 DPPC molecules by removed 4 lipids from upper leaflet when inserting protein into the lipid bilayer (252 lipids in the upper, 256 lipids in the lower leaflet). The steepest descent energy minimization was calculated to remove possible bad contacts from the initial structure until energy convergence reached 1000 kJ/(mol•nm). The simulation was performed in the NVT ensemble during 100 ps to stabilize the temperature of the system at 323 K. Continuously, equilibration of pressure is conducted under an NPT ensemble. The system was subjected to normal pressure constant (1 bar) for 1 ns under the conditions of position restraints for heavy atoms and LINCS [55] constraints for all bonds. Production run was carried out until 5 ns under periodic boundary conditions. Long range electrostatics interactions were calculated by the PME method. Cutoff distances for the calculation of the short-range electrostatic and van der Waals interaction were 1.2 nm. The time step of the simulation was set to 2 fs, and the coordinates were saved for analysis every 2 ps. All analyses of MD simulations were carried out using GROMACS package.
Molecular docking study
Molecular docking simulation was carried out to predict the binding modes of the blockers into the cavity of the mTRESK structure using GOLD 4.1 program [56] . The program uses genetic algorithm (GA) for docking of flexible ligands into protein binding sites. In this study, the GA parameters were set as default values. The reasonable internal binding site of mTRESK structure for K + channel blockers was identified by Find Sites from Receptor Cavities method in Define and Edit Binding site tools of DS2.5. The blockers such as propafenone, quinine, lidocaine, and triethanolamine obtained from ChEMBL (https://www.ebi.ac.uk/chembldb) were used for the docking simulation. A radius was taken as 10 Å around the center of binding site in mTRESK. The flip and rotate options were applied for protonated carboxylic acids, ring-NHR, and ring NR1R1 during the docking simulation. The best docked poses of compounds were selected based on the GoldScore ranking. The GOLD fitness score calculated by factors including H-bonding energy, van der Waals energy, and ligand torsion strain has been optimized for the prediction of ligand binding positions.
Transfection
Mouse TRESK (mTRESK, GenBank accession number NM_207261) was a kind gift from Dr. Donghee Kim. The coding region of TRESK was subcloned into pcDNA3.1/V5-His-TOPO vector (Invitrogen, Carlsbad, CA, USA). HEK-293A cells were seeded at a density of 2 × 10 5 cells per 35-mm dish 24 h prior to transfection in Dulbecco's modified Eagle's medium (DMEM) which included 10% fetal bovine serum (FBS; Invitrogen, Grand Island, NY, USA). HEK-293A cells were co-transfected with an mTRESK DNA in pcDNA3.1 and green fluorescent protein (GFP) in pcDNA3.1 using LipofectAMINE and Opti-MEM I Reduced Serum Medium (Invitrogen). The cells expressing GFP were detected with a microscope (Axiovert 135; Carl Zeiss Jena GmbH, Jena, Germany) equipped with a mercury lamp light source. Cells were used 1-3 days after transfection.
Site-directed mutagenesis
Single and double point mutations in mTRESK cDNA were done using a QuikChange site-directed mutagenesis kit (Stratagene, Santa Clara, CA, USA) to generate penylalanin-to-alanine mutations according to the instructions of the manufacturer (F156A, F364A, and F156A/F364A). Both strands of mutated TRESK DNA fragments were sequenced for confirmation.
Electrophysiological studies
Electrophysiological recording was performed using a patch clamp amplifier (Axopatch 200, Axon Instruments, Union City, CA). Whole-cell currents were analyzed with the pCLAMP program (Version 8). Bath solution for whole-cell recording contained (mM): 135 NaCl, 5 KCl, 1 CaCl 2 , 1 MgCl 2 , 5 glucose and 10 HEPES, and pipette solutions contained (mM):
150 KCl, 1 MgCl 2 , 5 EGTA and 10 HEPES (pH 7.3). All other chemicals were purchased from Sigma Chemical Co. (St Louis, MO, USA).
Statistical analysis
Data were analyzed using one-way ANOVA with Tukey's test used for post hoc comparisons. All analyses were performed using SPSS (version18, Chicago, IL, USA) and represented as the mean ± SD. Differences were considered significant at p b 0.05.
Results and discussion
Prediction of number and topology for transmembrane helices
The number of transmembrane helices (TMHs) and transmembrane topology for mTRESK were predicted by TMHMM v2.0 server using a hidden Markov model. The results showed that TRESK has six TMHs consisting of each three TMH at N-terminal and C-terminal, respectively. The second and fifth TMHs were identified as P-loop domains which are including conserved P-loop sequences (TxGxG). The long extended loops such as TM1-P1 and TM2-TM3 loops were observed in the plot showing posterior probabilities of inside/outside/TM helix (Fig. S1 ). According to Kang D et al., mTRESK has four TMHs, two P-loop domains, extracellular TM1-P1 loop, and the extended intracellular TM2-TM3 loop [21] . The mTRESK topology obtained from TMHMM was used to generate 3D structure of mTRESK.
Sequence alignment for the homology modeling
Sequence alignments of several reported K + channel structures (PDB ID: 2AHZ for NaK channel, 1XL4 for KirBac3.1 channel, 3LDC for MthK, and 1J95 for KcsA) were performed for selecting the proper template structure. Since MthK channel (PDB ID: 3LDC), which is in open state rather than the closed state, was well aligned with mTRESK, the structure was used as template. All K + channels have a highly conserved TVGYG motif (P-loop sequence) which is responsible for selectivity filter. Since one subunit of mTRESK contains two P-loops (P1-loop and P2-1oop) unlike other K + channels, TM1-P1-TM2 and TM3-P2-TM4 regions of mTRESK were separately aligned with MthK channel (Fig. 1) . The aligned sequence in P1 helix region was edited by removing gap region (ESWTVS-LYW → ESWTVSLYW) which makes collapse in the secondary structure of the P1 helix. The sequence alignment result for TM1-P1-TM2 region showed 13.7% identity and 29.4% similarity with the template (Fig. 1A) . When considering only TM region of TM1-P1-TM2 without TM1-P1 linker, sequence identity and similarity were slightly increased to 29.4% and 53.6%, respectively. This is due to structural property of K 2P family; they possess extended extracellular TM1-P1 loop region. Although relatively low identity of TM1-P1-TM2 region was observed, P1-loop of the region was perfectly aligned. In case of TM3-P2-TM4, sequence identity and similarity was 27.0% and 52.8%, respectively (Fig. 1B) . From these sequence alignment results, the sequences of the both TM1-P1-TM2 and TM3-P2-TM4 regions in mTRESK were found to be similar with that of the template. The P-loops were also found to be conserved well in mTRESK with the template. Thus, the alignment was used to generate 3D structure of mTRESK.
Generation of 3D structures using MthK as a template
Based on the TMHMM and sequence alignment results, the 3D structures of TM regions for mTRESK were generated using homology modeling method (Fig. 2) . The structure consists of six TMHs containing TM1-TM4, P1, and P2 helices (Fig. 1A) . Two different models were separately constructed and named as Model1 and Model2 depending on type of the TM1-P1 loop. The Model1 suggests the 3D structure of TM regions without the loop (Fig. 2A) . The Model2 represents not only TM regions but also the extended loop including two helices which are predicted by Secondary Structure Prediction and constructed by Build and Edit Protein tools (Fig. 2B) .
To obtain monomer and homodimer (dimer and tetramer, in case of MthK) formation of mTRESK, crystal structure of KcsA (PDB ID: 1J95) which consists of tetramer was used to form functional channel for two models (Fig. 2C, D , and E). In order to refine the homology modeled structures, calculation of solvated energy minimization was carried out and then the final structures were achieved.
After our modeling study was completed, the X-ray crystal structures of the K 2P channels, TWIK-1 and TRAAK, were currently solved [60, 61] . The structures reveal the presence of a novel extracellular helical cap domain that creates a bifurcated pore entryway. Although we could not predict disulfide bond that covalently links the two subunits, prediction of a part of two helices of the Model2 is corresponding with the crystal structure (Fig. S4A) . Since the main aim of this study was to find out the blocker binding site rather than to construct the extracellular region, the results of this modeling study will be continuously used for further study.
Validation for the structural quality
The PROCHECK, ProSA-Web, and ERRAT programs were performed to validate the refined model structures, and these results are detailed in Table 1 . The PROCHECK, a well-known protein structure checking program was carried out to check stereochemical quality of homology modeled structures and MthK structure (Fig. S2) . Ramachandran plot obtained from the PROCHECK showed that the 98.6% residues of MthK structure and more than 90% residues of modeled 3D structures were lied in the most favored regions: 97.2% for Model1 and 93.2% for Model2 (Fig. S2A and B) . Especially, the higher stereochemical quality score was observed in the Model1 compared to that of the Model2. There was no residue in disallowed region of Model1 structure and only two residues in Model2 (Table 1) . These results indicated that our models are reasonable because the spot distributions were similar to the template structure. Moreover, overall Goodness factor (G-factor) indicating the quality of covalent and overall bond-angle distances was 0.12 for Model1, 0.03 for Model2. The G-factor is a measure of the overall 'normality' of the structure which provided from an average of all the different G-factors of each residue in the structure [57] . Generally, the G-factor should be above -0.5 for a dependable structure. It means our structures are acceptable.
The z-score of two models was calculated using ProSA-web to check overall model quality. The proper z-score values (within −2.6) were observed in the two modeled structures compared with that of the template (−1.65). As the result, our structures are within the range of scores typically found for native proteins of similar size which are experimentally determined protein chains in current PDB [42] .
ERRAT is protein structure verification algorithm for non-bonded atomic interactions between different atom types. The recommended value of ERRAT is greater than 50 for higher quality model, and the higher scores indicate the better quality [43] . In the case of our models, each ERRAT value was 66.88, and 76.78 for Model1 and Model2, respectively. Although low values of two models were observed when compared with that of the template which is 100, the models were found within the range of a high quality model. All the validation results revealed that our models were successfully constructed.
Structural comparison of pore region with template
A Model1 was used to compare pore region with template (Fig. 3) . In order to compare pore region of Model1 with that of template, the two structures were superimposed as shown in the Fig. 3A . Each RMSD value for TM1-P1-TM2 region (Fig. 3A) and TM3-P2-TM4 region (Fig. 3C) was calculated as 0.26 and 0.28 Å, respectively. Moreover, the P-loops of the homology modeled structure were completely identical, and it showed that our model can form properly pore which is responsible for K + ion permeation (Fig. 3B and D) . The pore radius analysis of mTRESK and MthK channels was carried out using HOLE program. The different gate region between mTRESK and MthK channels was observed through the analysis. The narrow pore radius (within 0.5-1.0 Å) of selectivity filter was detected in the both structures and the values are almost similar (Fig. 4) . However, in the case of the gate region, the narrower pore radius was investigated in mTRESK structure compared to the template ( Fig. 4B and C) . The radius of gate region in the MthK was approximately 4Å, but that of the mTRESK structure was displayed as 2 Å (Fig. 4C) . Although the both structures are in open state, around two fold differences were observed in the size of pore radius of gate regions. This reason is considered that the mTRESK structure has four phenylalanine residues, F156 of TM2 and F364 of TM4 in each monomer, around gate region (Fig. 4B) . This result suggests that these residues can be form a narrow pore surrounding with volume of the residues through the assembly of dimer.
In order to compare pore regions between TRAAK and the mTRESK, we performed additional pore radius analysis for the TRAAK, it showed that the region was more wider than mTRSEK. The gate region in TRAAK has different amino acids such as glycine (TM2) and alanine (TM4) (Fig. S4 ).
Selection of representative structure for molecular docking
Generally, blockers of K + channel can be bound on either side of the membrane at each binding site (external or internal) [58] . In this study, in order to find out blocker binding site from the overall structure of mTRESK, we selected internal site which was identified by Define and Edit Binding site Tools in DS2.5. Sano Y et al. revealed that human TRESK (hTRESK) was inhibited by K + channel blockers such as propafenone, glyburide (ATP-sensitive K + channel blocker), lidocaine (Na + channel blocker), quinine, quinindine, and triethanolamine (non-selective K + channel blocker) [8] . Since there is no reported specific blocker for the mTRESK, these reported blocker compounds including propafenone, quinine, lidocaine, and triethanolamine were selected as blockers of mTRESK (Fig. 5) .
To investigate the binding mode of the blockers into the binding site, molecular docking was used and then MD simulation was carried out to refine blocker bounded structure in a dipalmitoylphosphatidylcholine (DPPC) bilayer (Fig. 6) . Firstly, four blockers were docked into the internal binding site of the protein structure to obtain the initial blocker bound structure. All of the blockers were well docked into internal binding site, and the conformations were placed in same position and binding mode. Since the propafenone of blockers has shown the highest fitness score compared to the others, propafenone bound complex was used to MD simulation. Before the MD simulation, the implicit membrane was added to mTRESK structure using Add Membrane and Orient Molecule protocol to better understand the topology of the membrane as well as to gain orientation of the structure in membrane environment (Fig. 6A  and B) . The 5 ns MD simulation of the propafenone bounded mTRESK model embedded in a lipid bilayer (Fig. 6C ) was performed to acquire adjusted protein conformation by propafenone as well as to refine homology model in explicit membrane environment. The backbone root mean square deviation (RMSD) achieves stability after approximately 2500 ps and its average value was 0.42 nm during simulation time. In addition stability of propafenone also adjusted after about 1500 ps and maintained 0.2 nm until the end of the simulation (Fig. 6D) . Based on these RMSD analyses, representative structures (4570 ps frame) as ligand bound form was selected from the last 2 ns snapshots. Refined representative structure was utilized to molecular docking study.
Prediction of blocker binding site
Molecular docking study was carried out to find out suitable blocker binding site using refined representative structure (Fig. S3) . As previous docking simulation, four blockers such as propafenone, quinine, lidocaine, and triethanolamine were docked to representative structure of mTRESK ( Fig. S3A ) and all of blockers showed similar binding mode to internal binding site of the mTRESK (Fig. S3B) . The highest fitness score (64.77) was obtained in the case of propafenone, and the respective score of the other compounds, quinine, lidocaine, and triethanolamine was 53.90, 46.78, and 30.56, respectively. Among the blockers, especially the triethanolamine showed the lowest fitness score (30.56). The reported experimental study from Sano Y et al. also showed that triethanolamine (2 mM) blocked TRESK by 34%, whereas propafenone (0.05 mM), quinine (0.1 mM), and lidocaine (1 mM) inhibited TRESK by more than 70% [1, 8] . The reported experimental results were found to be in accordance with our docking results showing the effect of pi (π) interactions in ligand binding. In the docking results, three blockers except for triethanolamine were participated in the π interactions with hydrophobic residues of mTRESK (Fig. 7) . Several key interacting residues for the docked blockers were detected, and its residues are listed in Table 2 . Almost interacting residues in each complex were located in TM2 (I152, F156, L157, L159, T160, and D161) and TM4 (F364, I365, F367, K368, and L369). In addition, T335 belongs to P2-loop was detected as hydrophobic interacting residue with lidocaine and triethanolamine. Especially, all blockers but triethanolamine contain aromatic ring groups (Fig. 5) , the blockers (propafenone, quinine, and lidocaine) have formed π-π stacking interaction with two phenylalanine residues, F364 and F367 which are located in TM4 of mTRESK (Fig. 7A, B and C) . According to hERG K + channel study by Masetti M et al. [59] , aromatic residues including tyrosine and phenylalanine were formed cation-π and π-π stacking interaction with K + channel blockers. Our docking results also showed similar the π-π stacking interactions which were observed between the aromatic ring groups of the blockers and the two phenylalanine residues. Particularly, the quinine has more π-π stacking interaction compared with others due to the presence of quinoline group (Fig. 7B) . Whereas, the triethanolamine docking result revealed that the F364 residue of mTRESK structure was formed only one hydrogen bond with H atom of hydroxyl group in triethanolamine (Fig. 7D) . Therefore, π interaction seems to be strong effect on blocker binding in mTRESK. Interestingly, when we compared this docking result with previous pore radius analysis, we found that the key interacting residues F156 and F364 were also involved into the formation of narrow cavity in gate region. It can be concluded that the phenylalanine residues are critical key residues for both binding of the blockers and forming the narrow gate region. From our molecular docking simulation, we can understand not only plausible binding mode of known K + channel blockers into the mTRESK but also significant key residues of mTRESK.
Modulation of mTRESK by pharmacological agents
In order to validate our modeling study, we tested the affinity of F156 and F364 for mTRESK channels expressed in HEK-293A cells in respond to TRESK blockers. Phenylalanine residues of mTRESK were mutated to alanine (F156A, F364A, and F156A/F364A) at the TM2 and TM4, and each mutant was expressed in HEK-293A cells. In physiological bath solution containing 5 mM KCl, the membrane potential of cells under the whole-cell configuration was held at −80 mV, and then a ramp pulse (−120 to +60 mV; 1-s duration) was applied. In control cells transfected with plasmid containing GFP alone, the ramp pulse elicited very small currents (b0.2 nA at +60 mV; n = 6). However, in cells transfected with TRESK/GFP DNA, the same ramp pulse produced large currents (b 10 nA at +60 mV; n = 6; Fig. 8 ) with reversal potentials near -80 mV, indicating that wild-type (WT) and mutant mTRESK formed a functional K + channel in the plasma membrane of HEK-293 cells. All of the mutants expressed functional currents in transfected cells, as judged by measurement of single-channel and whole-cell current (Fig. 8A) . The single-channel was observed before recording whole-cell currents (upper left hand side in Fig. 8A ). WT and mutant mTRESK were studied under same conditions, but cells showed Table 2 Key interacting residues in blocker binding obtained from final docked conformations. different amount of mTRESK currents. These results suggest that each cell may control transcription and translation levels differently. Under whole-cell conditions, extracellular application of 100 μM bupivacaine, 1 mM lidocaine, and 100 μM quinine decreased WT currents by 82±
4%, 83 ± 5%, and 82± 8%, respectively. F156A and F364A mutants are less sensitive to quinine, lidocaine, and bupivacaine compared with WT. In F156A and F364A mutants, bupivacaine, lidocaine, and quinine inhibited the currents by 70 ± 10% and 58± 10%, 78± 12% and 40± 12%, and 76 ± 8% and 38± 9%, respectively. The mTRESK currents generated by these mutants were similar to those generated by WT (Fig. 8) .
To test the importance of phenylalanine at the two amino acid residues (F156 and F364), a double mutant was constructed and tested for sensitivity to quinine, lidocaine, and bupivacaine. F156A/F364A double mutant was insensitive to the blockers. Bupivacaine, lidocaine, and quinine slightly inhibited the currents of F156A/F364A mutant by 15± 14%, 20± 15%, and 18±11%, respectively. The % of inhibition by blockers was significantly small compared with that in WT currents (pb 0.05, Fig. 8A and B) . Also the amounts reduced by blockers in F156A/F364A current were also significantly lower than those in F364A current (Fig. 8B) .
Additional computational study was carried out to investigate the binding mode difference between the mutants and WT. Three compounds such as bupivacaine, lidocaine, and quinine which were used in experimental study were docked into each mutant structure. In comparison of the mutants with WT, each fitness score for the compounds with mutants was slightly lower than for those with WT. As shown in Table S1 , the fitness scores are not showing definite correlation with measured current inhibition for the blockers. In this study, the fitness scores were used to find out the proper ligand binding position with key interacting residues rather than to find out quite exact correlation with binding affinities because the fitness score has been optimized for the prediction of ligand binding positions [56] . In binding mode analysis, we found that while the single mutants (F156A or F364A) showed π interactions with aromatic ring group of the compounds, the double mutant (F156A/F364A) had no corresponding interactions (Fig. S5) . Thus, these results are consistent with experimental study, showing low current in double mutants.
To identify whether non-blockers of TRESK also affect F156 and F364 sites of TRESK, 9-anthracene carboxylic acid (9-AC), a chloride channel blocker, and tetraethylammonium (TEA), a K + channel blocker but not TRESK, were applied to WT and mutant TRESK currents overexpressed in HEK-293A cells. As shown in Fig. 9 , the 9-AC did not inhibit TRESK currents in WT and all mutants (F156A, F364A, and F156A/F364A).
TEA slightly inhibited TRESK currents. The inhibition amounts by TEA were 4 ±8%, 4 ± 7%, 2 ± 8%, and 9 ± 4% in WT, F156A, F364A, F156A/ F364A, respectively. 
Conclusions
The aims of this study were to obtain reasonable 3D structure and to find out the proper binding site of K + channel blockers. The 3D structure was built by homology modeling with considering the TM topology of mTRESK obtained from TMHMM prediction. The minimized final structures were achieved for subsequent molecular docking and MD simulations. In pore radius analysis, similar pore radius of selectivity filter was observed in mTRESK compared with template structure, whereas pore dimension of gate region was narrower than that of the template. This narrow dimension was caused by four phenylalanine residues consisting of F156 and F364 located in each monomer. The representative structure of the ligand-adjusted protein conformation was obtained from molecular docking and 5 ns MD simulation with DPPC lipid bilayer. The conformation was used for final molecular docking for the blockers. From our docking study, the plausible binding mode of known K + channel blockers was investigated into the mTRESK internal binding site, and key interacting residues were identified. Especially, two phenylalanine residues, F156 and F364, were considered as critical key residues for blocker binding. This prediction was tested by mutations of F156A, F364A, and F156A/F364A, and the results support the importance of these residues. Based on these results we can conclude that our modeled structure and docking results are reliable as a model for finding the binding mode properly. Our study is first modeling study of TRESK to provide structural knowledge including ligand binding information. Furthermore, this would be helpful to structure-based drugs design for TRESK as a potential therapeutic target in the reducing of pain. 
